Attenuation of the Hemodynamic Response to Double-lumen Endotracheal Intubation With Nebulized Lidocaine

RenJi Hospital92 enrolled

Overview

The goal of this clinical trial is to test the effect of nebulized lidocaine on the hemodynamic response in the participant undergoing double-lumen endotracheal intubation. The main question it aims to answer is to evaluate the changes in mean arterial pressure after intubation. Participants will inhale 5ml of 2% lidocaine by nebulization15min before intubation. Researchers will compare saline group to see if saline effects

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

QUADRUPLE

Enrollment

Conditions

Lung Neoplasms

Interventions

LidocaineDRUG

inhale 5ml of 2% lidocaine by nebulization

SalineDRUG

inhale 5ml of saline by nebulization

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. aged 18-65 years, American Society of Anesthesiologists class I-II 2. participants undergoing double-lumen endotracheal intubation under general anesthesia 3. signed informed consent and volunteered to participate in the experiment Exclusion Criteria: 1. Poor control of hypertension 2. preoperative arrhythmia 3. severe coronary artery or heart valve disease 4. sequelae of cerebrovascular accident 5. severe lung, liver, kidney and immune system diseases 6. Suspected difficult airway 7. confirmed or suspected allergy to this trial drug 8. As judged by the investigator to be ineligible for the study, such as communication impairment (language or intelligence)

Outcomes

Primary Outcomes

mean arterial pressure after intubation

Time frame: Immediately after intubation

Central Contacts

Hao Zhu

CONTACT

008602168383702 zhuhaossmu@163.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.